GOLDMAN SACHS GROUP INC - BRIACELL THERAPEUTICS CORP ownership

BRIACELL THERAPEUTICS CORP's ticker is BCTX and the CUSIP is 10778Y302. A total of 25 filers reported holding BRIACELL THERAPEUTICS CORP in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
GOLDMAN SACHS GROUP INC ownership history of BRIACELL THERAPEUTICS CORP
ValueSharesWeighting
Q1 2023$701,790
+1089.5%
94,200
+748.0%
0.00%
Q2 2021$59,00011,1080.00%
Other shareholders
BRIACELL THERAPEUTICS CORP shareholders Q2 2021
NameSharesValueWeighting ↓
Lynwood Capital Management Inc. 750,000$7,605,0008.16%
K.J. Harrison & Partners Inc 1,351,782$13,749,0002.21%
Redmond Asset Management, LLC 137,942$1,399,0000.42%
SABBY MANAGEMENT, LLC 29,962$304,0000.04%
Concord Wealth Partners 16,775$170,0000.04%
Leonard Green & Partners, L.P. 500,000$5,070,0000.04%
Summit Trail Advisors, LLC 35,000$355,0000.03%
WASATCH ADVISORS LP 244,691$2,481,0000.01%
Apollon Wealth Management, LLC 13,900$141,0000.01%
NATIONAL BANK OF CANADA /FI/ 156,900$1,591,0000.01%
View complete list of BRIACELL THERAPEUTICS CORP shareholders